HAX1 mutations causing severe congenital neuropenia and neurological disease lead to cerebral microstructural abnormalities documented by quantitative MRI-Reference-Cited by-同舟云学术

HAX1 mutations causing severe congenital neuropenia and neurological disease lead to cerebral microstructural abnormalities documented by quantitative MRI

Published:2010-11-24 Issue:12 Volume:152A Page:3157-3163
ISSN:1552-4825
Container-title:American Journal of Medical Genetics Part A
language:en
Short-container-title:Am. J. Med. Genet.

Author:

Boztug Kaan,Ding Xiao-Qi,Hartmann Hans,Ziesenitz Lena,Schäffer Alejandro A.,Diestelhorst Jana,Pfeifer Dietmar,Appaswamy Giridharan,Kehbel Sonja,Simon Thorsten,Al Jefri Abdullah,Lanfermann Heinrich,Klein Christoph

Publisher

Wiley

Subject

Genetics(clinical),Genetics

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/ajmg.a.33748/fullpdf

Reference35 articles.

1. A novel human primary immunodeficiency syndrome caused by deficiency of the endosomal adaptor protein p14;Bohn;Nat Med,2007

2. Novel genetic etiologies of severe congenital neutropenia;Boztug;Curr Opin Immunol,2009

3. A syndrome with congenital neutropenia and mutations in G6PC3;Boztug;N Engl J Med,2009

4. Infantile genetic agranulocytosis, morbus Kostmann: Presentation of six cases from the original “Kostmann family” and a review;Carlsson;Acta Paediatr,2001

5. Kostmann syndrome: Severe congenital neutropenia associated with defective expression of Bcl-2, constitutive mitochondrial release of cytochrome c, and excessive apoptosis of myeloid progenitor cells;Carlsson;Blood,2004

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Molecular functions of HAX1 during disease progress;Virus Genes;2024-07-11

2. HAX1: A versatile, intrinsically disordered regulatory protein;Biochimica et Biophysica Acta (BBA) - Molecular Cell Research;2023-10

3. Pediatric myelodysplastic syndrome;Seminars in Diagnostic Pathology;2023-05

4. Anti-apoptotic HAX-1 suppresses cell apoptosis by promoting c-Abl kinase-involved ROS clearance;Cell Death & Disease;2022-04-04

5. Immunodeficiency, Leukemia, and Lymphoma;Interdisciplinary Cancer Research;2022